The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Surgical Versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Incidentalomas: A Prospective Randomized Study
Open accessAbstract
OBJECTIVE: To compare the clinical outcome of patients with subclinical Cushing syndrome (SCS) due to an adrenal incidentaloma (the autonomous hypersecretion of a small amount of cortisol, which is not enough to cause clinically-evident disease) who underwent surgery or were managed conservatively. SUMMARY BACKGROUND DATA: The most appropriate management of SCS patients is controversial, either adrenalectomy or close follow-up being recommended for their treatment. METHODS: Over a 15-year period, 45 SCS patients were randomly selected to undergo surgery (n = 23) or conservative management (n = 22). All surgical procedures were laparoscopic adrenalectomies performed by the same surgeon. All patients were followed up (mean, 7.7 years; range, 2-17 years) clinically by 2 experienced endocrinologists 6 and 12 months after surgery and then yearly, or yearly after joining the trial, particularly monitoring diabetes mellitus (DM), arterial hypertension, hyperlipidemia, obesity, and osteoporosis. The study end point was the clinical outcome of SCS patients who underwent adrenalectomy versus those managed conservatively. RESULTS: All 23 patients in the surgical arm had elective surgery. Another 3 patients randomly assigned to conservative management crossed over to the surgical group due to an increasing adrenal mass >3.5 cm. In the surgical group, DM normalized or improved in 62.5% of patients (5 of 8), hypertension in 67% (12 of 18), hyperlipidemia in 37.5% (3 of 8), and obesity in 50% (3 of 6). No changes in bone parameters were seen after surgery in SCS patients with osteoporosis. On the other hand, some worsening of DM, hypertension, and hyperlipidemia was noted in conservatively-managed patients. CONCLUSIONS: Based on the results of this study, laparoscopic adrenalectomy performed by skilled surgeons appears more beneficial than conservative management for SCS patients complying with our selection criteria. This trial is registered with Australian Clinical Trials Registry number, ANZCTR12608000567325.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Rossi, R., Tauchmanovà, L., Luciano, A., Martino, M. D., Battista, C., Viscovo, L. D., Nuzzo, V., & Lombardi, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6515 · Cited by 416
Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
Assalia, A., & Gagner, M. (2004) · British journal of surgery · doi:10.1002/bjs.4738 · Cited by 308
Subclinical Cushing’s syndrome
Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285
Subclinical Cushing’s syndrome in adrenal incidentalomas
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.008 · Cited by 179
Chidiac, R. M., & Aron, D. C. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70242-5 · Cited by 140
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours
Fernández‐Real, J. M., Ricart Engel, W., Simó, R., Salinas, I., Webb, S. M., & and the Study Group of Incidental Adrenal Adenoma (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00437.x · Cited by 109
Flagged first, then by citations
Research works printed but not linked: 1
- Brunaud, 2006, Observation or laparoscopic adrenalectomy for adrenal incidentaloma?, Med Sci Monit, 12, 355
Cited by
Sorted by citations
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Faßnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J. D. C., Pelsma, I. C. M., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 849
“144,145 However, the evaluation and treatment of comorbidities in operated and nonoperated patients after randomization were not standardized, preventing an accurate assessment of the benefits of surgery.”
BackgroundAME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V., Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 523
“(156) carried on a prospective study in which 45 patients with subclinical Cushing‟s syndrome were randomly selected”
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“Several studies have reported the outcome of surgical intervention but most involve small numbers and are retrospective, uncontrolled, and lack randomization (230,243,250-253,255) (Table 7).”
BackgroundApproach to the patient with an adrenal incidentaloma
Nieman, L. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0457 · Cited by 290
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
“Nonetheless, as observed by the authors, these data suggest that surgical treatment is more beneficial than conservative treatment (57).”
BackgroundCortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas
Debono, M., Bradburn, M., Bull, M., Harrison, B., Ross, R. J., & Newell-Price, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3007 · Cited by 269
Elhassan, Y. S., Alahdab, F., Prete, A., Delivanis, D. A., Khanna, A., Prokop, L., Murad, M. H., O'Reilly, M. W., Arlt, W., & Bancos, I. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3630 · Cited by 263
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study
Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3527 · Cited by 223
“Some studies (22-26), but not all (27, 28), reported an improvement of the metabolic complications of SH (AH, weight, and glycemic control) and of the quality of life after adrenalectomy, while a worsening of these conditions in untreated patients.”
BackgroundChiodini, I., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2387 · Cited by 191
Chiodini, I., Morelli, V., Masserini, B., Salcuni, A. S., Eller-Vainicher, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Carnevale, V., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0468 · Cited by 168
Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology
Di Dalmazi, G., Pagotto, U., Pasquali, R., & Vicennati, V. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/525093 · Cited by 168
“5% of patients after a mean followup of 8 years [119].”
BackgroundBancos, I., Alahdab, F., Crowley, R. K., Chortis, V., Delivanis, D. A., Erickson, D., Natt, N., Terzolo, M., Arlt, W., Young, W. F., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0465 · Cited by 167
“Most studies reassessed patients at least 6 months after the surgery (n=17, Table 3) with a median follow up of 28 (1-109) months (median or mean follow up was reported only in 11 studies).”
Kebebew, E. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp2031112 · Cited by 155
Clinical guidelines for the management of adrenal incidentaloma
Lee, J.-M., Kim, M. K., Ko, S.-H., Koh, J.-M., Kim, B.-Y., Kim, S. W., Kim, S.-K., Kim, H. J., Ryu, O.-H., Park, J., et al. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.200 · Cited by 147
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
Guidelines for the management of the incidentally discovered adrenal mass
Kapoor, A., Morris, T., & Rebello, R. (2011) · Canadian Urological Association Journal · doi:10.5489/cuaj.11135 · Cited by 137
Medical and Surgical Evaluation and Treatment of Adrenal Incidentalomas
Zeiger, M. A., Siegelman, S. S., & Hamrahian, A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0085 · Cited by 135
Androulakis, I. I., Kaltsas, G., Κόλλιας, Γ., Markou, Α., Gouli, A., Thomas, D. A., Alexandraki, K., Papamichael, C. M., Hadjidakis, D., & Piaditis, G. P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4064 · Cited by 135
“Although an improvement in CVR factors after the removal of AI causing SCS appears to be beneficial (42, 43), the available data regarding a similar approach in NFAIs are conflicting.”
ResultSubclinical Cushing’s syndrome: definition and management
Terzolo, M., Pia, A., & Reimondo, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04253.x · Cited by 131
Pelsma, I. C. M., Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad134 · Cited by 130
“65,66 Furthermore, most studies were downgraded for imprecision, due to the small number of events.”
InfluentialSubclinical hypercortisolism: a state, a syndrome, or a disease?
Dalmazi, G. D., Pasquali, R., Beuschlein, F., & Reincke, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0272 · Cited by 126
Di Dalmazi, G., Berr, C. M., Fassnacht, M., Beuschlein, F., & Reincke, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1401 · Cited by 139
Arnaldi, G., & Boscaro, M. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.006 · Cited by 120
Morelli, V., Masserini, B., Salcuni, A. S., Eller‐Vainicher, C., Savoca, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Iorio, L., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03794.x · Cited by 107
Patrova, J., Kjellman, M., Wahrenberg, H., & Falhammar, H. (2017) · Endocrine · doi:10.1007/s12020-017-1400-8 · Cited by 109
Iacobone, M., Citton, M., Viel, G., Boetto, R., Bonadio, I., Mondi, I., Tropea, S., Nitti, D., & Favia, G. (2012) · Surgery · doi:10.1016/j.surg.2012.08.054 · Cited by 101
“Some reports, however, have documented a worsening of symptoms or enlargement of the adrenal mass during a longer follow up.(14,24) Thus, there appears to be a need for a careful long-term monitoring in patients receiving conservative management.”
Yanase, T., Oki, Y., Katabami, T., Otsuki, M., Kageyama, K., Tanaka, T., Kawate, H., Tanabe, M., Doi, M., Akehi, Y., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0456 · Cited by 90
“However, there are no results of a deterioration in blood pressure or glucose tolerance upon surgery; instead improvement (or at least an unchanged result) has been reported [24, 31-34] (Table 4).”
BackgroundCushing Syndrome: Maybe Not So Uncommon of an Endocrine Disease
Guaraldi, F., & Salvatori, R. (2012) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2012.02.110227 · Cited by 86
MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors
Patel, D., Boufraqech, M., Jain, M., Zhang, L., He, M., Gesuwan, K., Gulati, N., Nilubol, N., Fojo, T., & Kebebew, E. (2013) · Surgery · doi:10.1016/j.surg.2013.06.022 · Cited by 86
“The widespread use of computed tomography (CT) has resulted in an increase in incidentally detected adrenal masses termed adrenal incidentalomas (1).”
BackgroundDennedy, M. C., Annamalai, A. K., Smith, O. P., Freeman, N., Vengopal, K., Graggaber, J., Koulouri, O., Powlson, A., Shaw, A., Halsall, D. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2718 · Cited by 83
Autonomous cortisol secretion in adrenal incidentalomas
Castro, M. A., Núñez, M. A. S., & Marazuela, M. (2019) · Endocrine · doi:10.1007/s12020-019-01888-y · Cited by 76
Eller-Vainicher, C., Morelli, V., Salcuni, A. S., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., Carnevale, V., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0775 · Cited by 75
Aron, D. C., Terzolo, M., & Cawood, T. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.06.012 · Cited by 74
Salcuni, A. S., Morelli, V., Eller-Vainicher, C., Palmieri, S., Cairoli, E., Spada, A., Scillitani, A., & Chiodini, I. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0977 · Cited by 74
Eller-Vainicher, C., Morelli, V., Salcuni, A. S., Battista, C., Torlontano, M., Coletti, F., Iorio, L., Cairoli, E., Beck-Peccoz, P., Arosio, M., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0602 · Cited by 73
Systematic review of surgical treatment of subclinical Cushing's syndrome
Iacobone, M., Citton, M., Scarpa, M., Viel, G., Boscaro, M., & Nitti, D. (2015) · British journal of surgery · doi:10.1002/bjs.9742 · Cited by 74
Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s Syndrome
Alesina, P. F., Hommeltenberg, S., Meier, B., Petersenn, S., Lahner, H., Schmid, K. W., Mann, K., & Walz, M. K. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0453-0 · Cited by 68
“Recently, a randomized study [ 33 ] comparing surgical (22 cases) versus conservative (23 cases) treatment of sCS concluded that in the surgical group, diabetes normalized or improved in 62.5% of patients (5 of 8), hypertension in 67% (12 of 18), hyperlipidemia in 37.5% (3 of 8), and central obesity in 50% (3 of 6), a…”
InfluentialMorelli, V., Palmieri, S., Lania, A., Tresoldi, A., Corbetta, S., Cairoli, E., Eller-Vainicher, C., Arosio, M., Copetti, M., Grossi, E., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0047 · Cited by 67
Glucose metabolism in patients with subclinical Cushing’s syndrome
Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E., & Arvat, E. (2012) · Endocrine · doi:10.1007/s12020-012-9628-9 · Cited by 64
Subclinical Cushing’s syndrome
Leo, M. D., Cozzolino, A., Colao, A. A. L., & Pivonello, R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.02.001 · Cited by 65
Vassilatou (2014) · doi:10.1530/eje-13-0848 · Cited by 61
Vassiliadi, D. A., Ntali, G., Vicha, E., & Tsagarakis, S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03963.x · Cited by 61
The clinical significance of adrenal incidentalomas
Androulakis, I. I., Kaltsas, G., Piaditis, G. P., & Grossman, A. B. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02436.x · Cited by 61
Stewart, P. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0633 · Cited by 61
Olsen, H., Nordenström, E., Bergenfelz, A., Nyman, U., Valdemarsson, S., & Palmqvist, E. (2012) · Endocrine · doi:10.1007/s12020-012-9622-2 · Cited by 60
Debono, M., Chadarévian, R., Eastell, R., Ross, R. J. M., & Newell-Price, J. D. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060984 · Cited by 60
“A number of studies have been carried out in individuals with cortisol secreting incidentalomas who have been subjected to adrenalectomy [26,27] and improvements have been noted in weight, blood pressure, lipid profiles, fibrinogen levels, and glycemic control [11,28,29,30,31].”
BackgroundMorelli, V., Frigerio, S., Aresta, C., Passeri, E., Pugliese, F., Copetti, M., Barbieri, A. M., Fustinoni, S., Polledri, E., Corbetta, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.898084 · Cited by 59
Palmieri, S., Morelli, V, Polledri, E., Fustinoni, S., Mercadante, R., Olgiati, L., Eller Vainicher, C., Cairoli, E., Zhukouskaya, V. V., Beck-Peccoz, P., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0803 · Cited by 57
Pros and cons of screening for occult Cushing syndrome
Tabarin, A., & Perez, P. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.51 · Cited by 57
“A beneficial effect of surgery has been suggested in most studies”
BackgroundCohort study of patients with adrenal lesions discovered incidentally
Muth, A., Hammarstedt, L., Hellström, M., Sigurjónsdóttir, H. Á., Almqvist, E. G., & Wängberg, B. (2011) · British journal of surgery · doi:10.1002/bjs.7566 · Cited by 55
Debono, M., Prema, A., Hughes, T., Bull, M., Ross, R. J. M., & Newell-Price, J. D. C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4276 · Cited by 53
Differences between bilateral adrenal incidentalomas and unilateral lesions
Pasternak, J. D., Seib, C. D., Seiser, N., Tyrell, J. B., Liu, C., Cisco, R. M., Gosnell, J. E., Shen, W. T., Suh, I., & Duh, Q.-Y. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.1683 · Cited by 50
Cardiovascular complications of mild autonomous cortisol secretion
Aresta, C., Favero, V., Morelli, V., Giovanelli, L., Parazzoli, C., Falchetti, A., Pugliese, F., Gennari, L., Vescini, F., Salcuni, A. S., et al. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101494 · Cited by 53
Acharya, R., Dhir, M., Bandi, R., Yip, L., & Challinor, S. M. (2018) · World Journal of Surgery · doi:10.1007/s00268-018-4788-2 · Cited by 48
Six controversial issues on subclinical Cushing’s syndrome
on behalf of the ABC Group, Chiodini, I., Albani, A., Ambrogio, A. G., Campo, M., Martino, M. C. D., Marcelli, G., Morelli, V., Zampetti, B., Colao, A. A. L., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1017-3 · Cited by 47
Mortality in Patients with Endogenous Cushing’s Syndrome
Javanmard, P., Duan, D., & Geer, E. B. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.005 · Cited by 48
Cardiovascular and metabolic risk factors in patients with subclinical Cushing
Petramala, L., Olmati, F., Concistrè, A., Russo, R., Mezzadri, M., Soldini, M., Vincentis, G. D., Iannucci, G., Toma, G. D., & Letizia, C. (2020) · Endocrine · doi:10.1007/s12020-020-02297-2 · Cited by 50
Hardy, R., & Cooper, M. S. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.007 · Cited by 43
Peppa, Μ., Koliaki, C. C., & Raptis, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02291.x · Cited by 44
Akehi, Y., Kawate, H., Murase, K., Nagaishi, R., Nomiyama, T., Nomura, M., Takayanagi, R., & Yanase, T. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0458 · Cited by 42
Tabarin, A., Espiard, S., Deutschbein, T., Amar, L., Vezzossi, D., Dalmazi, G. D., Reznik, Y., Young, J., Desailloud, R., Goichot, B., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00062-2 · Cited by 46
Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)
Cohan, P., East, H. E., Galati, S.-J., Mercado, J. U., Lim, P. J., Lamerson, M., Smith, J. J., Peters, A. L., & Yuen, K. C. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02638 · Cited by 39
Surgical management of adrenocortical tumours
Miller, B. S., & Doherty, G. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.26 · Cited by 38
Adrenocortical tumors and insulin resistance: What is the first step?
Altieri, B., Tirabassi, G., Casa, S. D., Ronchi, C. L., Balercia, G., Orio, F., Pontecorvi, A., Colao, A., & Muscogiuri, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29950 · Cited by 39
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma
Ceccato, F., Barbot, M., Albiger, N., Antonelli, G., Zilio, M., Todeschini, M., Regazzo, D., Plebani, M., Lacognata, C., Iacobone, M., et al. (2018) · Endocrine · doi:10.1007/s12020-017-1421-3 · Cited by 38
Koh, J., Song, K., Kwak, M. K., Suh, S., Kim, B., Sung, T., Hong, J. H., Jeong, B. C., Kim, J. H., & Lee, S. H. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000006183 · Cited by 37
Endocrine incidentalomas—challenges imposed by incidentally discovered lesions
Vassiliadi, D. A., & Tsagarakis, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.92 · Cited by 37
Subclinical hypercortisolism in adrenal incidentaloma
Debono, M., & Newell-Price, J. D. C. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000151 · Cited by 37
“Results from studies have been conflicting but in general data indicate an improvement in metabolic complications, especially in blood pressure and diabetes, in some patients after adrenal surgery, and deterioration or no improvement in patients treated conservatively [15,45].”
BackgroundResultSubclinical Cushing’s syndrome: Current concepts and trends
Zografos, G. N., Perysinakis, I., & Vassilatou, E. (2014) · HORMONES · doi:10.14310/horm.2002.1506 · Cited by 33
Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas
Morelli, V., Eller-Vainicher, C., Palmieri, S., Cairoli, E., Salcuni, A. S., Scillitani, A., Carnevale, V., Corbetta, S., Arosio, M., Casa, S. D., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1423 · Cited by 34
Petramala, L., Cavallaro, G., Galassi, M., Marinelli, C., Tonnarini, G., Concistrè, A., Costi, U., Bufi, M., Lucia, P., Vincentis, G. D., et al. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0182-7 · Cited by 34
“These results are in accord with a recent prospective randomized study [16, 17] that showed in 26 surgically treated patients with SH, an improvement in obesity, hypertension, diabetes and dyslipidemia in 50, 66.”
ResultFrequently asked questions and answers (if any) in patients with adrenal incidentaloma
Ceccato, F., Barbot, M., Scaroni, C. M., & Boscaro, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01615-3 · Cited by 35
Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment
Akaza, I., Yoshimoto, T., Iwashima, F., Nakayama, C., Doi, M., Izumiyama, H., & Hirata, Y. (2011) · Hypertension Research · doi:10.1038/hr.2011.90 · Cited by 34
Management of adrenal incidentaloma: the role of adrenalectomy may be underestimated
Ye, Y., Yuan, X., Chen, M., Dai, Y., Qin, Z., & Zheng, F. (2016) · BMC Surgery · doi:10.1186/s12893-016-0154-1 · Cited by 35
“For instance, adrenalectomy is recommended for subclinical Cushing’s syndrome, which is related to longterm metabolic disorders [4].”
BackgroundOutcome of adrenalectomy for subclinical hypercortisolism and Cushing syndrome
Raffaelli, M., Crea, C. D., D’Amato, G., Gallucci, P., Lombardi, C. P., & Bellantone, R. D. A. (2016) · Surgery · doi:10.1016/j.surg.2016.07.042 · Cited by 32
Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome
Perysinakis, I., Marakaki, C., Avlonitis, S., Katseli, A., Vassilatou, E., Papanastasiou, L., Piaditis, G., & Zografos, G. N. (2013) · Surgical Endoscopy · doi:10.1007/s00464-012-2730-5 · Cited by 30
“Recent studies have confirmed better management of SCS by LA, emphasizing the improvement of several components of metabolic syndrome and the decrease in cardiovascular risk [8, 9, 24].”
BackgroundResultManagement of Dyslipidemia in Cushing’s Syndrome
Greenman, Y. (2010) · Neuroendocrinology · doi:10.1159/000314294 · Cited by 31
Management of adrenal incidentaloma
Ménégaux, F., Chéreau, N., Peix, J.-L., Christou, N., Lifante, J. C., Paladino, N. C., Sebag, F. A., Ghander, C., Trésallet, C., & Mathonnet, M. (2014) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2014.07.002 · Cited by 32
Miyazato, M., Ishidoya, S., Satoh, F., Morimoto, R., Kaiho, Y., Yamada, S., Ito, A., Nakagawa, H., Ito, S., & Arai, Y. (2011) · International Urology and Nephrology · doi:10.1007/s11255-011-9950-9 · Cited by 31
“Toniato et al. [ 6 ] reported that DM normalized or improved in 62.5%, hypertension in 67%, hyperlipidemia in 37.5%, and obesity in 50%, in the surgical group, whereas some worsening of these diseases was noted in conservatively managed patients with subclinical Cushing’s syndrome in a prospective randomized study.”
BackgroundResultInfluentialGoupil, R., Wolley, M. J., Ungerer, J. P. J., McWhinney, B. C., Mukai, K., Naruse, M., Gordon, R. D., & Stowasser, M. (2015) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-15-0075 · Cited by 31
Castro, M. A., Ojeda, C. M., Ramírez, M. N. S., Santos, V. G. D., Corrales, E. P., & Fernández-Argüeso, M. (2022) · Endocrine · doi:10.1007/s12020-022-03120-w · Cited by 30
Ricciato, M. P., Donna, V. D., Perotti, G., Pontecorvi, A., Bellantone, R. D. A., & Corsello, S. M. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2482-6 · Cited by 33
Lee, S. H., Song, K., Kim, J., Park, S., Ahn, S. H., Kim, H., Cho, Y. Y., Suh, S., Kim, B., Kim, J. H., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13145 · Cited by 29
Morelli, V., Minelli, L., Eller-Vainicher, C., Palmieri, S., Cairoli, E., Spada, A., Arosio, M., & Chiodini, I. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0788-6 · Cited by 29
Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity
Castro, M. A., Corrales, E. P., & Lamas, C. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.005 · Cited by 36
Kaštelan, D., Kraljević, I., Dušek, T., Knežević, N., Solak, M., Gardijan, B., Kralik, M., Poljičanin, T., Skoric‐Polovina, T., & Kaštelan, Ž. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0199 · Cited by 28
Ioachimescu, A. G., Remer, E. M., & Hamrahian, A. H. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.005 · Cited by 28
Guerrieri, M., Campagnacci, R., Patrizi, A., Romiti, C., Arnaldi, G., & Boscaro, M. (2010) · Surgical Endoscopy · doi:10.1007/s00464-010-1000-7 · Cited by 26
“[8] confirms the better management of SCS by LA for a group of 45 patients, emphasizing the decrease in cardiovascular risk after adrenalectomy.”
BackgroundInfluentialA multidisciplinary approach to the management of adrenal incidentaloma
Voltan, G., Boscaro, M., Armanini, D., Scaroni, C. M., & Ceccato, F. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1948327 · Cited by 27
“reported metabolic and cardiovascular improvement (weight, blood pressure, and glucose levels) in patients with autonomous cortisol secretion after surgery [110,111].”
BackgroundCurrent status and controversies in adrenal incidentalomas
Kaltsas, G., Chrisoulidou, A., Piaditis, G. P., Kassi, E. N., & Chrousos, G. P. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.001 · Cited by 26
Reimondo, G., Allasino, B., Bovio, S., Saba, L., Ardito, A., Angeli, A., & Terzolo, M. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346701 · Cited by 25
Castro, M. A., Reincke, M., & Lamas, C. (2023) · Biomedicines · doi:10.3390/biomedicines11123115 · Cited by 24
“There are two randomized clinical trials with results that were in favor of surgery [34,35].”
BackgroundGoddard, G. M., Ravikumar, A., & Levine, A. C. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.009 · Cited by 24
Maghrabi, A. H., Yaqub, A., Denning, K. L., BenHamed, N., Faiz, S., & Saleem, T. F. (2013) · Endocrine Practice · doi:10.4158/ep12277.ra · Cited by 24
Khadembashiri, M. M., Mohseni, S., Harandi, H., Sani, M. P., Khadembashiri, M. A., Atlasi, R., SeyedAlinaghi, S., Mohajeri‐Tehrani, M. R., & Larijani, B. A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1374711 · Cited by 24
Evaluation of patients with adrenal incidentalomas
Kannan, S., Remer, E. M., & Hamrahian, A. H. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328360a43b · Cited by 23
WFUMB position paper on the management incidental findings: adrenal incidentaloma
Dietrich, C. F., Correas, J. M., Dong, Y., Nolsøe, C., Westerway, S. C., & Jenssen, C. (2019) · ULTRASONOGRAPHY · doi:10.14366/usg.19029 · Cited by 21
“The indications for uni lateral (or very rarely bi lateral) adrenalectomy [86] are beyond the scope of this review [87-89].”
BackgroundManagement of adrenal incidentalomas: Working through uncertainty
Cambos, S., & Tabarin, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101427 · Cited by 22
Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids
Warriner, A. H., & Saag, K. G. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/01.med.0000436249.84273.7b · Cited by 22
“As such, some have recommended the consideration of laproscopic adrenalectomy in affected patients [22,23].”
Background
Metadata
- Authors
- Toniato, A., Merante-Boschin, I., Opocher, G., Pelizzo, M. R., Schiavi, F., & Ballotta, E.
- Affiliations
- University of Padua (IT)
- Istituto Oncologico Veneto (IT)
- Corresponding author
- Toniato, Antonio
- Pelizzo, Maria R.
- Schiavi, Francesca
- Venue
- Annals of Surgery
- Published
- 2009-03
- Volume
- 249
- Issue
- 3
- Pages
- 388-391
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2067421446
- Cited by
- 245
- References
- 21
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 6 · 2023: 14 · 2022: 11 · 2021: 12 · 2020: 10 · 2019: 13 · 2018: 10 · 2017: 13 · 2016: 25 · 2015: 15 · 2014: 18 · 2013: 17 · 2012: 24
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Annals of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- subclinical Cushing's syndrome, adrenal incidentaloma, laparoscopic adrenalectomy, conservative treatment, cortisol hypersecretion, diabetes mellitus, hypertension, hyperlipidemia, obesity, osteoporosis, long-term clinical outcomes
- MeSH terms
- Adrenal Gland Neoplasms, Adrenalectomy, Aged, Cushing Syndrome, Female, Humans, Male, Middle Aged, Laparoscopy, Prospective Studies, Incidental Findings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review